Takeda Pharmaceutical Non-GAAP EPS of ¥517.00, revenue of ¥4505.7B; gives FY2026 forecast

Citadel Securities called the stock-market reset. Now it says leverage may build up again.

08/12/2026

Regeneron, Tenet leads top healthcare companies with highest earnings beats

08/12/2026

Bio-Techne declares $0.08 dividend

08/12/2026

Lazard AUM rises to $286.9B in July

08/12/2026